<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">9815831</journal-id><journal-id journal-id-type="pubmed-jr-id">22061</journal-id><journal-id journal-id-type="nlm-ta">Genet Med</journal-id><journal-id journal-id-type="iso-abbrev">Genet. Med.</journal-id><journal-title-group><journal-title>Genetics in medicine : official journal of the American College of Medical Genetics</journal-title></journal-title-group><issn pub-type="ppub">1098-3600</issn><issn pub-type="epub">1530-0366</issn></journal-meta><article-meta><article-id pub-id-type="pmid">25232856</article-id><article-id pub-id-type="pmc">4364924</article-id><article-id pub-id-type="doi">10.1038/gim.2014.125</article-id><article-id pub-id-type="manuscript">NIHMS624318</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Uptake of <italic>BRCA1/2</italic> Genetic Testing in a Randomized Trial of Telephone Counseling</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Butrick</surname><given-names>Morgan</given-names></name><degrees>ScM</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kelly</surname><given-names>Scott</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Peshkin</surname><given-names>Beth N.</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Luta</surname><given-names>George</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Nusbaum</surname><given-names>Rachel</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Hooker</surname><given-names>Gillian W.</given-names></name><degrees>ScM, PhD</degrees><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Graves</surname><given-names>Kristi</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Feeley</surname><given-names>Lisa</given-names></name><degrees>BS</degrees><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Isaacs</surname><given-names>Claudine</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>B.Valdimarsdottir</surname><given-names>Heiddis</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Jandorf</surname><given-names>Lina</given-names></name><degrees>MA</degrees><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>DeMarco</surname><given-names>Tiffani</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wood</surname><given-names>Marie</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>McKinnon</surname><given-names>Wendy</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Garber</surname><given-names>Judy</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>McCormick</surname><given-names>Shelley R.</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>Schwartz</surname><given-names>Marc D.</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="A2">2</xref></contrib></contrib-group><aff id="A1"><label>1</label>Laboratory of Immunology, National Institute of Allergy and Infectious Disease, National Institute of Health, Bethesda, MD 20892</aff><aff id="A2"><label>2</label>Cancer Prevention and Control Program and Fisher Center for Familial Cancer Research, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC</aff><aff id="A3"><label>3</label>Department of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC</aff><aff id="A4"><label>4</label>Social and Behavioral Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA</aff><aff id="A5"><label>5</label> Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029</aff><aff id="A6"><label>6</label>Familial Cancer Program of the Vermont Cancer Center, University of Vermont College of Medicine, Burlington, Vermont</aff><aff id="A7"><label>7</label>Center for Cancer Genetics and Prevention, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts</aff><author-notes><corresp id="CR1">Contact information for corresponding author: Marc D. Schwartz, PhD, Lombardi Comprehensive Cancer Center, 3300 Whitehaven Street, NW, Suite 4100, Washington, DC 20007, USA; Tel.: 202- 687-0185; Fax: 202-687-8444; <email>schwartm@georgetown.edu</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>2</day><month>9</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>18</day><month>9</month><year>2014</year></pub-date><pub-date pub-type="ppub"><month>6</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>12</day><month>5</month><year>2016</year></pub-date><volume>17</volume><issue>6</issue><fpage>467</fpage><lpage>475</lpage><!--elocation-id from pubmed: 10.1038/gim.2014.125--><permissions><license xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms"><license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:<ext-link ext-link-type="uri" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</ext-link></license-p></license></permissions><abstract><sec id="S1"><title>Purpose</title><p id="P1">As genetic counseling and testing become more fully-integrated into clinical care, alternative delivery models are increasingly prominent. This study examines predictors of genetic testing for hereditary breast/ovarian cancer among high-risk women in a randomized trial of in-person vs. telephone-based genetic counseling.</p></sec><sec id="S2"><title>Methods</title><p id="P2">Methods include multivariable logistic regression and interaction analyses.</p></sec><sec id="S3"><title>Results</title><p id="P3">Of the 669 participants, 600 completed counseling and 523 received test results. As previously reported, participants randomized to telephone counseling were significantly less likely to be tested. In intention to treat analyses, completion of counseling and testing was associated with: race/ethnicity (OR = 1.96, 95% CI: 1.20-3.20), , perceived stress (OR = 0.89, 95% CI: 0.81-0.98, knowledge (OR=1.12, 95% CI: 1.02-1.23), and randomization group (OR = 1.48, 95% CI: 1.01-2.16).. Further, race/ethnicity moderated the association between randomization group and testing, where minority women receiving telephone counseling were least likely to complete testing.</p></sec><sec id="S4"><title>Conclusion</title><p id="P4">Evidence for logistical and communication-based explanations for this interaction are presented. The overall increased access made possible with telephone genetic counseling should be considered in light of the possibility that this may also lead to lower rates of testing among high-risk minority women. Additional care should be taken to assess and address potential barriers when services are delivered by phone.</p></sec></abstract><kwd-group><kwd>Cancer</kwd><kwd>genetic counseling</kwd><kwd>genetic testing</kwd><kwd>psychosocial predictors</kwd><kwd>telephone counseling</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="S5"><title>INTRODUCTION</title><p id="P5">Genetic testing of the <italic>BRCA1</italic> and <italic>BRCA2</italic> (<italic>BRCA1/2</italic>) genes has become standard of care for women at risk for hereditary breast and ovarian cancer (HBOC). While comprehensive genetic counseling is recommended (<xref rid="R1" ref-type="bibr">1</xref>, <xref rid="R2" ref-type="bibr">2</xref>) this service is not always accessible given the small size and unequal distribution of the genetic counseling workforce (<xref rid="R3" ref-type="bibr">3</xref>). Thus, in practice, this need may be addressed by having non-geneticist physicians, such as the patient's OB/GYN, primary care doctor, surgeon, or oncologist order <italic>BRCA1/2</italic> testing. The ordering of <italic>BRCA1/2</italic> testing by non-genetics professionals may or may not be accompanied by adequate genetic counseling and result interpretation (<xref rid="R4" ref-type="bibr">4</xref>, <xref rid="R5" ref-type="bibr">5</xref>). However, an increasingly common alternative approach to service delivery is for genetics professionals to deliver preand/or post-test genetic counseling by telephone (<xref rid="R6" ref-type="bibr">6</xref>-<xref rid="R8" ref-type="bibr">8</xref>). Despite the increasing use of telephone counseling, little is known about how telephone delivery of genetic services impacts the receipt of counseling or uptake of testing.</p><p id="P6">We recently completed a randomized noninferiority trial that demonstrated that delivering genetic counseling via telephone (TC) led to outcomes that were noninferior to standard in-person genetic counseling (UC or usual care) for HBOC. Specifically, TC was noninferior to UC on knowledge, satisfaction, decisional conflict, quality of life and distress (<xref rid="R9" ref-type="bibr">9</xref>). In addition, TC yielded a cost savings of $114 per patient counseled compared to UC (<xref rid="R9" ref-type="bibr">9</xref>). Although concerns exist regarding potential limitations of or adverse outcomes related to telemedicine generally (<xref rid="R10" ref-type="bibr">10</xref>, <xref rid="R11" ref-type="bibr">11</xref>) and telephone genetic counseling specifically (<xref rid="R12" ref-type="bibr">12</xref>, <xref rid="R13" ref-type="bibr">13</xref>), these data support the use of TC as a safe and cost-effective approach to increase access to genetic services for HBOC (<xref rid="R9" ref-type="bibr">9</xref>).</p><p id="P7">Notably, however, in this trial we found that women who were randomized to TC were less likely to complete <italic>BRCA1/2</italic> testing than women randomized to UC (<xref rid="R9" ref-type="bibr">9</xref>). The lower rate of genetic testing for TC participants was replicated in another recent trial comparing telephone and in-person genetic counseling (<xref rid="R14" ref-type="bibr">14</xref>). There are several plausible explanations for this difference. Since participants who received TC did not have the option of providing DNA for testing immediately after counseling, the built-in delay with TC may have been a barrier to testing. Alternatively, the delay may have allowed increased time for deliberation among TC participants leading some women to decide not to proceed with testing. Although these structural differences are plausible, it is also possible that unmeasured genetic counseling process differences (e.g., differences in rapport or needs assessment between TC and UC) contributed to this difference.</p><p id="P8">If telephone delivery of genetic counseling is to be part of the solution to the shortage and uneven distribution of genetics professionals, a better understanding of how TC impacts uptake of genetic testing is needed. The increasing use of panel-based genetic testing for cancer susceptibility only underscores the need for understanding the factors contributing to counseling and test uptake with alternative delivery models, as greater demand is being placed on the professionals delivering this service. Specifically, identifying factors that contribute to the lower uptake of genetic testing following TC could facilitate improved tailoring and delivery of TC. For example, TC may not be uniformly appropriate for all patients, based on their medical, socio-demographic or psychological characteristics.</p><p id="P9">In this report we examined socio-demographic, medical, and psychosocial predictors of genetic testing uptake and we evaluated whether there were patient-related moderators that contributed to lower genetic testing uptake following TC. Specifically, we tested the following moderator variables based on prior literature (<xref rid="R15" ref-type="bibr">15</xref>, <xref rid="R16" ref-type="bibr">16</xref>): knowledge, numeracy, race/ethnicity, education, perceived and objective mutation risk and distress. We examined these putative moderators within both our intention-to-treat (ITT) and per-protocol (PP) samples. The ITT population reflects the comparison between UC and TC with respect to both attending genetic counseling <bold><underline>and</underline></bold> obtaining <italic>BRCA1/2</italic> results, whereas the PP analyses reflect a comparison of test uptake following receipt of in-person vs. telephone genetic counseling.</p></sec><sec sec-type="methods" id="S6"><title>MATERIALS AND METHODS</title><sec sec-type="subjects" id="S7"><title>Participants</title><p id="P10">Participants were women who were enrolled in a randomized noninferiority trial comparing standard genetic counseling to telephone-based genetic counseling (<xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R17" ref-type="bibr">17</xref>). From 2005-2012, we enrolled women who were self- or physician-referred to the genetic counseling programs at the Lombardi Comprehensive Cancer Center (Washington, DC), Icahn School of Medicine at Mount Sinai (New York, NY), University of Vermont Cancer Center (Burlington, VT), and the Dana Farber Cancer Institute (Boston, MA). Eligible participants were women age 21-85 who sought <italic>BRCA1/2</italic> genetic counseling, had not received prior counseling or testing, did not have newly diagnosed or metastatic breast or ovarian cancer, lived within the catchment area of one of our study sites and agreed to be randomized to telephone vs. in-person genetic counseling. As displayed in <xref ref-type="fig" rid="F1">Figure 1</xref>, of 1,057 potentially eligible women, 669 (63.3%) completed a baseline interview and agreed to be randomized to telephone counseling (N=335) vs. in-person counseling (N=334). This report focuses on baseline (i.e., pre-randomization) predictors of the completion of genetic testing within this trial.</p></sec><sec sec-type="methods" id="S8"><title>Procedures</title><p id="P11">Eligible patients completed a pre-counseling telephone interview with a research assistant to collect demographic, cancer history and psychosocial information. Following the interview, we explained the study, obtained verbal consent and randomized consenting participants via computer-generated random numbers to either usual care (in-person genetic counseling; UC) or telephone genetic counseling (TC). The UC and TC interventions are explained in detail in other reports (<xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R17" ref-type="bibr">17</xref>). UC participants completed both their initial session and result disclosure session in-person. TC participants completed both sessions by telephone. The study was approved by the Institutional Review Boards of the participating sites.</p></sec><sec id="S9"><title>Measures</title><sec id="S10"><title>Socio-demographics</title><p id="P12">We assessed age, education, marital status, race/ethnicity, employment and Jewish ancestry. For analysis we treated age as a continuous variable but created binary variables for education (college graduate vs. less than college graduate), marital status (married/partnered vs. unmarried/unpartnered), race/ethnicity (non-Hispanic white vs. racial/ethnic minority), employment (full time vs. less than full time), Jewish ancestry (Jewish vs. non-Jewish).</p></sec><sec id="S11"><title>Medical History</title><p id="P13">We assessed personal and family cancer history in order to calculate an a priori risk score using BRCAPRO (<xref rid="R18" ref-type="bibr">18</xref>). We used BRCAPRO score as a single composite of objective risk rather than using individual measures of personal cancer history and breast and ovarian cancer family history (all of which are components of and highly correlated with BRCAPRO score).</p></sec><sec id="S12"><title>Intentions for risk reducing surgery</title><p id="P14">We created a binary variable to reflect baseline intentions for risk reducing mastectomy (RRM) or risk reducing oophorectomy (RRO). Participants who reported that they were not considering RRM or RRO served as the reference group (n=353). This group included: participants who had already had both surgeries (n=24); participants who had one of the surgeries but were not considering the other (n=125); and participants who had neither surgery and were not considering either in the future (n=204). These participants were contrasted with participants who reported that they were considering RRM, RRO or both (n=316).</p></sec><sec id="S13"><title>Perceived risk of a BRCA mutation</title><p id="P15">We measured perceived risk with the following 5-point Likert style item: &#x0201c;In your opinion, how likely is it that you have an altered breast-ovarian cancer gene?&#x0201d; We dichotomized this variable for analysis as &#x0201c;very likely and above&#x0201d; vs. &#x0201c;somewhat likely and below&#x0201d; based on response distribution.</p></sec><sec id="S14"><title>Perceived risk of breast cancer and perceived risk of ovarian cancer</title><p id="P16">We measured perceived risk for breast and ovarian cancer with separate 5-point Likert response items. For both we dichotomized the responses at &#x0201c;very likely and above&#x0201d; vs. &#x0201c;somewhat likely and below&#x0201d; based on response distribution.</p></sec><sec id="S15"><title>Knowledge</title><p id="P17">We measured <italic>BRCA1/2</italic> knowledge with the 27-item Breast Cancer Genetic Counseling Knowledge scale (<xref rid="R19" ref-type="bibr">19</xref>). Total score was the number of correct responses. Cronbach's alpha for this sample was 0.78.</p></sec><sec id="S16"><title>Numeracy</title><p id="P18">We measured numeracy with Lipkus&#x02019; 3-item scale (<xref rid="R20" ref-type="bibr">20</xref>). The number of items answered correctly was summed to create a total numeracy score (range 0&#x02013;3). Cronbach's alpha was 0.74.</p></sec><sec id="S17"><title>Decisional Conflict</title><p id="P19">We measured decisional conflict regarding <italic>BRCA1/2</italic> testing with the 10-item version of the Decisional-Conflict Scale (DCS) (<xref rid="R21" ref-type="bibr">21</xref>). Items are scored on a weighted 3-point scale (Yes (0)/Unsure (2)/No (4)) with higher scores indicating greater decisional conflict. We calculated a total score by multiplying the average item score by 25. Cronbach's alpha was 0.82.</p></sec><sec id="S18"><title>Distress</title><p id="P20">We measured cancer-specific distress with the total score on the 15-item Impact of Event Scale (IES) (<xref rid="R20" ref-type="bibr">20</xref>). Cronbach's alpha was 0.88. We measured global perceived stress with the 4-item version of the Perceived Stress Scale (PSS) (<xref rid="R22" ref-type="bibr">22</xref>). PSS items are rated on a 5-point Likert scale and summed for a total score. Cronbach's alpha was 0.69.</p></sec><sec id="S19"><title>Quality of Life</title><p id="P21">We measured quality of life with the SF-12 (<xref rid="R23" ref-type="bibr">23</xref>). The SF-12 has two subscales, the Mental Component Summary (MCS) and the Physical Component Summary (PCS). Higher scores reflect better quality of life. Due to complex scoring procedures we relied on published SF-12 internal consistency data (Cronbach's alpha = 0.86 and 0.87 (<xref rid="R25" ref-type="bibr">25</xref>).</p></sec></sec><sec id="S20"><title>Statistical Analyses</title><p id="P22">We conducted analyses separately for the intention to treat (ITT) and per protocol (PP) populations. We used t-tests and Chi-square tests to identify bivariate associations with completion of genetic testing in the entire sample (ITT population) and limited to those who completed a genetic counseling session (PP population). To identify independent main effect predictors, we used multiple logistic regression with backward elimination in which we started with all variables with p&#x0003c;0.10 for bivariate associations with the outcome of interest. To identify variables that modified the association between randomization group and counseling/testing completion we conducted exploratory analyses of the following potential moderator variables: knowledge, numeracy, race/ethnicity, education level, perceived and objective mutation risk and distress (IES and PSS). For each of these putative moderators we conducted separate multiple logistic regressions in which we added the main effect term for the moderator (if not already in the final model) and the group by moderator interaction term to the final main effects model. All analyses were conducted using SAS, version 9.3.</p></sec></sec><sec sec-type="results" id="S21"><title>RESULTS</title><sec id="S22"><title>Sample Characteristics</title><p id="P23">The participants were predominantly non-Hispanic white (82.7%), affected with cancer (65.3% with breast or ovarian cancer), college-educated or greater (79.7%), and married (62.3%). Participants had a mean age of 47.7 years (SD = 13.4) and had a mean BRCAPRO risk score of 25.0% (SD = 22.9). The TC and UC groups did not differ significantly on any socio-demographic variables (p &#x0003e; .05).</p><p id="P24">As previously reported, of the 669 participants in the trial, 600 (89.7%) completed an initial genetic counseling session and the TC and UC groups did not differ on genetic counseling participation (UC = 90.4%, TC = 89.0%; p=0.53) (<xref rid="R9" ref-type="bibr">9</xref>). Also as previously reported, 523 participants received genetic testing results representing 78.2% of all participants and 87.2% of participants who completed an initial genetic counseling session. The TC and UC groups differed significantly on genetic testing uptake within the ITT sample (UC=81.4% vs. TC=74.9%; X<sup>2</sup> (N=699) = 4.16, df=1, p=0.04) and the PP sample (UC=90.1% vs. TC=84.2% (X<sup>2</sup> N=600 = 4.57, df=1, p=0.03).</p></sec><sec id="S23"><title>Genetic Counseling and Testing Completion: Intention to Treat Population</title><p id="P25">As shown in <xref ref-type="table" rid="T1">Table 1</xref>, significant bivariate predictors of completing genetic testing in the full sample were: being randomized to UC (X<sup>2</sup> = 4.16, df=1, p = 0. 042), higher knowledge (t= 2.80, df=667, p=0.005), lower perceived stress (t = 2.29, df=200.68 (satterthwaite), p=0.023), non-Hispanic white race/ethnicity (X<sup>2</sup>=6.48, df=1, p=0.011) and higher education (X<sup>2</sup>=5.76, df=1, p=0.016). Jewish ancestry (X<sup>2</sup> = 3.39, df=1, p = 0.066) and being married/partnered (X<sup>2</sup> = 3.03, df=1, p=0.082) were marginally associated with completing genetic counseling and testing.</p><p id="P26">To identify independent main effect predictors of completing genetic counseling and testing, we included all variables with p&#x0003c;0.10 for bivariate associations with genetic counseling/testing completion in the initial step of a backward elimination procedure for the logistic regression model. The following variables remained in the final model indicating that they were independently associated with the completion of <italic>BRCA1/2</italic> genetic counseling and testing: non-Hispanic white race/ethnicity (OR = 1.96, 95% CI: 1.20-3.20), perceived stress (OR = 0.89, 95% CI: 0.81-0.98), knowledge (OR = 1.12, 95% CI: 1.02-1.23) and randomization group (OR = 1.48, 95% CI: 1.01-2.16) (<xref ref-type="table" rid="T2">Table 2</xref>). Participants randomized to UC, those with higher knowledge, lower perceived stress and non-Hispanic white participants were more likely to complete genetic counseling and <italic>BRCA1/2</italic> testing.</p><p id="P27">We tested the following patient variables as potential moderators of the association between randomization group and completion of genetic testing: race/ethnicity, knowledge, education, numeracy, distress and objective and perceived risk for carrying a <italic>BRCA1/2</italic> mutation. We tested each of the potential moderators separately by adding their main effect term (if not already in the model) and the randomization group by moderator interaction term to the final main effect model described above. Only the group by race/ethnicity interaction approached statistical significance (p=.054). As displayed in <xref ref-type="fig" rid="F2">Figure 2</xref>, within the UC group, 76.2% of minority participants completed counseling and <italic>BRCA1/2</italic> testing compared to 82.1% of non-Hispanic white participants (OR=0.88, 95% CI: 0.40-1.94). Within the TC group, 53.1% of minority participants completed counseling and <italic>BRCA1/2</italic> testing compared to 78.9% of non-Hispanic white participants (OR=0.33, 95% CI: 0.17-0.62).</p></sec><sec id="S24"><title>Genetic Testing Among Those Who Completed a Counseling Session: Per Protocol Population</title><p id="P28">As displayed in <xref ref-type="table" rid="T1">Table 1</xref>, significant bivariate predictors of <italic>BRCA1/2</italic> testing among those who completed a genetic counseling visit were: randomization to UC (X<sup>2</sup> = 4.57, df=1, p = 0. 033), higher knowledge (t= -2.56, df=598, p=0.011), Jewish ancestry (X<sup>2</sup> = 3.01, df=1, p = 0.083), being married/partnered (X<sup>2</sup> = 5.14, df=1, p=0.023), intentions for risk reducing surgery (X<sup>2</sup> = 4.91, df=1, p = 0. 027) higher objective risk as measured by BRCAPRO score (t=-2.69, df=598, p=0.007) and non-Hispanic white race/ethnicity (X<sup>2</sup> = 3.38, df=1, p=0.066).</p><p id="P29">As above, we included all variables with p&#x0003c;0.10 for bivariate associations with genetic testing in the initial step of a backward elimination procedure for the logistic regression model. The following were independently associated with utilization of <italic>BRCA1/2</italic> genetic testing: marital status (OR = 1.85, 95% CI: 1.12-3.08), BRCAPRO probability (OR = 1.22, 95% CI: 1.06-1.41), knowledge (OR = 1.13, 95% CI: 1.00-1.27), and randomization group (OR = 1.65, 95% CI: 1.00-2.72) (<xref ref-type="table" rid="T2">Table 2</xref>). The odds of undergoing <italic>BRCA1/2</italic> testing were higher for participants who were married, had higher objective risk, greater knowledge and were randomized to UC.</p><p id="P30">We evaluated the same potential moderator variables as above. Only the race/ethnicity by group interaction was statistically significant (p=.028; data for null-interactions not presented). As displayed in <xref ref-type="fig" rid="F3">Figure 3</xref>, among participants who completed an in-person genetic counseling session, race/ethnicity was not associated with undergoing <italic>BRCA1/2</italic> testing. Specifically, 94.2% of minority participants completed <italic>BRCA1/2</italic> testing compared to 89.4% of non-Hispanic white participants (OR = 2.75, 95% CI: 0.61-12.50). In contrast, race/ethnicity was significantly associated with testing among participants who completed a TC session with 68.4% of minority participants completing <italic>BRCA1/2</italic> testing compared to 87.0% of non-Hispanic white participants (OR=0.41, 95% CI: 0.18-0.92).</p></sec></sec><sec sec-type="discussion" id="S25"><title>DISCUSSION</title><p id="P31">The goal of this report was to better understand the lower rate of genetic testing completion among women who received telephone-based <italic>BRCA1/2</italic> counseling compared to women who received standard in-person counseling. We examined this question within our ITT and PP samples. It is particularly important to evaluate this question in both samples because the ITT population included all randomized participants regardless of whether they completed a genetic counseling session, and therefore reflects the comparison between UC and TC with respect to both attending genetic counseling <bold><underline>and</underline></bold> obtaining <italic>BRCA1/2</italic>. In contrast, the PP analyses were limited to participants who completed a genetic counseling session as assigned, and therefore reflects a comparison of test uptake following receipt of in-person vs. telephone genetic counseling.</p><p id="P32">Within the ITT population, independent predictors of genetic testing were: randomization group, race/ethnicity, perceived stress and knowledge. Within the PP population, independent predictors were: randomization group, knowledge, marital status and objective mutation risk. The fact that knowledge was a predictor in both populations suggests that knowledge prior to counseling may be a facilitator of attending counseling and of choosing to be tested following counseling. Knowledge did not interact with group assignment in either analysis. Similarly neither education nor numeracy interacted with group assignment, indicating that the impact of prior knowledge, education and numeracy were comparable for in person and telephone counseling.</p><p id="P33">Predictors that differed in the ITT and PP populations included objective risk, perceived stress, and marital status. Objective risk was associated with getting tested only among participants who completed a genetic counseling session. This suggests that the decision about whether to proceed with testing is appropriately influenced by knowledge of objective risk that is conveyed through genetic counseling. In contrast, perceived stress was associated with a decreased likelihood of completing genetic testing in the ITT but not PP analyses. This may suggest that perceived stress serves as a barrier to participating in counseling but became less important after counseling. Perhaps women who were experiencing moderate stress avoided the potential added stressor of genetic counseling. This is consistent with previous data highlighting the roles of stress and avoidant coping as barrier to completing the HBOC genetic testing process (<xref rid="R26" ref-type="bibr">26</xref>). Lastly, being married/partnered was associated with getting tested only among participants who completed a genetic counseling session. This suggests that the life-cycle stability of long-term partnership may create a more conducive environment for pursuing <italic>BRCA1/2</italic> testing and the subsequent risk-management decision-making (<xref rid="R27" ref-type="bibr">27</xref>, <xref rid="R28" ref-type="bibr">28</xref>).</p><p id="P34">Neither perceived stress nor objective risk interacted with group assignment suggesting that the effects of these variables were comparable in both TC and UC; interactions with marital status were not tested.</p><p id="P35">Given our previously reported difference in genetic testing uptake between the two groups (<xref rid="R9" ref-type="bibr">9</xref>), a key aim of this report was to explore moderators that could help to explain this unexpected difference. The only variable that moderated the association between group and genetic testing uptake was race/ethnicity. Compared to non-Hispanic white participants, minority participants were significantly less likely to undergo <italic>BRCA1/2</italic> testing when randomized to the telephone counseling and when limited to participants who completed an initial genetic counseling session but were no less likely than whites to be tested when randomized to in-person counseling or when limited to those who completed an in-person counseling session. The differential impact of race between UC and TC largely accounts for the overall uptake difference between these groups. Previous studies have reported lower rates of <italic>BRCA1/2</italic> testing for minority participants receiving standard in-person genetic counseling and testing (<xref rid="R15" ref-type="bibr">15</xref>, <xref rid="R29" ref-type="bibr">29</xref>, <xref rid="R30" ref-type="bibr">30</xref>) and have speculated on the contribution of access and awareness to decreased uptake. However, our sample focused on women who had self-referred for genetic counseling. Thus, our data suggest that the lower rate of counseling and testing in minority women cannot be fully explained by reduced access and awareness (<xref rid="R15" ref-type="bibr">15</xref>, <xref rid="R16" ref-type="bibr">16</xref>).</p><p id="P36">There are several plausible explanations for the lower rate of testing among minority women in the TC arm. For all women receiving TC, the logistics of completing testing may have served as a barrier. Whereas, UC participants could provide DNA immediately following their genetic counseling session, TC participants had to travel to a doctor's office, lab or the genetic counseling clinic to provide DNA. It is possible that these practical barriers may have been more important for minority participants. For example, evidence suggests that minorities are less likely to have a regular healthcare provider to go to for DNA provision (<xref rid="R31" ref-type="bibr">31</xref>). Second, a recent report (<xref rid="R32" ref-type="bibr">32</xref>) indicates that non-white participants experience high and clinically significant levels of distress and depression related to genetic counseling and testing. For participants experiencing this distress during genetic counseling, choosing not to pursue testing may be a coping strategy. This line of evidence suggests that particular attention be paid to assessing distress during the initial genetic counseling session.</p><p id="P37">Third, it is possible that unmeasured genetic counseling process differences may have differentially impacted minority participants. While explicit biases are rare, social patterns related to race/ethnicity from the dominant culture are evident in health care communication across almost all services and illnesses (<xref rid="R33" ref-type="bibr">33</xref>-<xref rid="R38" ref-type="bibr">38</xref>). Thus, minority patients often receive slightly poorer and less patient-centered communication from their providers. Further, there is some evidence that TC increases specific negative communication patterns, such as less rapport building, increased verbal dominance by the health care provider, and fewer problems disclosed by patients (<xref rid="R11" ref-type="bibr">11</xref>, <xref rid="R39" ref-type="bibr">39</xref>). Thus, it is possible that the telephone delivery of genetic counseling compounded such existing differences in verbal and non-verbal communication to minority participants. To our knowledge, no process studies have directly investigated the effect of telephone vs. in-person counseling on communication with minority and racial majority patients.</p><p id="P38">The present findings suggest that clinicians should consider the possibility that delivering counseling via telephone may lead to lower rates of <italic>BRCA1/2</italic> genetic testing among minority women. However, this concern should be balanced with the possibility that offering telephone delivery may increase access in the first place (<xref rid="R40" ref-type="bibr">40</xref>). Thus, the question of whether overall rates of testing would be increased with the availability of telephone delivery remains to be answered. However, for those women who do complete telephone genetic counseling, additional care should be taken to assess and address potential barriers to completing genetic testing. With the availability of buccal sampling for DNA provision, it is possible that one of the major barriers to completing testing could be greatly minimized. Despite the undefined mechanism for the interaction between race/ethnicity and randomization group, these findings suggest that attention to communication quality and responding to signs of distress for all patients, but especially for minority patients receiving genetic counseling by telephone, may address potential aspects of the identified discrepancy in testing uptake.</p><p id="P39">Our study had several limitations. First, because the study sample was comprised of participants in a randomized trial, these results may not be generalizable to the larger population of women seeking genetic counseling and testing. Specifically, the overall completion rate of both counseling and testing may be higher than in the general population. It is also possible that some of the participants who did not complete genetic counseling may have chosen to receive counseling and testing outside of the study protocol. Although at least two of the enrolled women who did not complete genetic counseling as part of this protocol went on to receive clinical genetic counseling through one of our programs, it is possible that some women pursued genetic counseling elsewhere. Additionally, although this large multi-site study enrolled a sample that reflects the typical genetic counseling population, the fact remains that the sample was primarily non-Hispanic white and well-educated. Also, the heterogeneous minority race/ethnicity categorization did not allow sufficient power to investigate more specific associations between race/ethnicity and uptake. Lastly, although studying many psychosocial and biomedical associations, this study did not seek to characterize <italic>patient-reported</italic> reasons for test uptake or lack there of; the collection of that type of information could have further contextualized our findings.</p><p id="P40">Despite these limitations, the present study provides information about the potential barriers and facilitators to genetic testing across two modes of clinical service delivery. These results indicate an interaction between race and randomization group, such that minority women assigned to telephone counseling are the least likely to complete genetic testing and it is this difference that makes up the majority of differential uptake between randomization groups. As other modes of delivery emerge for genetic counseling and testing, attention to factors that influence uptake and outcomes will be important.</p></sec></body><back><ack id="S26"><p>Grant support: National Cancer Institute Grants R01 CA108933, P30 CA051008 and the Jess and Mildred Fisher Center for Familial Cancer Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.</p></ack><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>National Comprehensive Cancer Network</collab></person-group><source>NCCN Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian. V.1.2014</source><comment><ext-link ext-link-type="uri" xlink:href="http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf">http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf</ext-link></comment></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>U.S. Preventive Services Task Force</collab></person-group><source>Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Draft Recommendation Statement. April 2013. AHRQ Publication No. 12-05164-EF-2</source><comment><ext-link ext-link-type="uri" xlink:href="http://www.uspreventiveservicestaskforce.org/uspstf12/brcatest/draftrecbrcatest.htm">http://www.uspreventiveservicestaskforce.org/uspstf12/brcatest/draftrecbrcatest.htm</ext-link></comment></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>National Society of Genetic Counselors</collab></person-group><source>Professional Status Survey: Executive Summary</source><year>2012</year><comment><ext-link ext-link-type="uri" xlink:href="http://nsgc.org/p/cm/ld/fid=68">http://nsgc.org/p/cm/ld/fid=68</ext-link></comment></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brierley</surname><given-names>KL</given-names></name><name><surname>Blouch</surname><given-names>E</given-names></name><name><surname>Cogswell</surname><given-names>W</given-names></name><etal/></person-group><article-title>Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications.</article-title><source>Cancer J</source><year>2012</year><volume>18</volume><issue>4</issue><fpage>303</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">22846730</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vig</surname><given-names>HS</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name></person-group><article-title>The evolution of personalized cancer genetic counseling in the era of personalized medicine.</article-title><source>Fam Cancer</source><year>2012</year><volume>11</volume><issue>3</issue><fpage>539</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">22419176</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumanis</surname><given-names>L</given-names></name><name><surname>Evans</surname><given-names>JP</given-names></name><name><surname>Callanan</surname><given-names>N</given-names></name><name><surname>Susswein</surname><given-names>LR</given-names></name></person-group><article-title>Telephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfaction.</article-title><source>J Genet Couns</source><year>2009</year><volume>18</volume><issue>5</issue><fpage>447</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">19462222</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradbury</surname><given-names>AR</given-names></name><name><surname>Patrick-Miller</surname><given-names>L</given-names></name><name><surname>Fetzer</surname><given-names>D</given-names></name><etal/></person-group><article-title>Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results.</article-title><source>Clin Genet</source><year>2011</year><volume>79</volume><issue>2</issue><fpage>125</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">21039431</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wham</surname><given-names>D</given-names></name><name><surname>Vu</surname><given-names>T</given-names></name><name><surname>Chan-Smutko</surname><given-names>G</given-names></name><name><surname>Kobelka</surname><given-names>C</given-names></name><name><surname>Urbauer</surname><given-names>D</given-names></name><name><surname>Heald</surname><given-names>B</given-names></name></person-group><article-title>Assessment of clinical practices among cancer genetic counselors.</article-title><source>Fam Cancer</source><year>2010</year><volume>9</volume><issue>3</issue><fpage>459</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">20140525</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>MD</given-names></name><name><surname>Valdimarsdottir</surname><given-names>HB</given-names></name><name><surname>Peshkin</surname><given-names>BN</given-names></name><etal/></person-group><article-title>Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.</article-title><source>J Clin Oncol</source><year>2014</year><volume>32</volume><issue>7</issue><fpage>618</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">24449235</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKinstry</surname><given-names>B</given-names></name><name><surname>Sheikh</surname><given-names>A</given-names></name></person-group><article-title>Unresolved questions in telephone consulting.</article-title><source>J R Soc Med</source><year>2006</year><volume>99</volume><issue>1</issue><fpage>2</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">16388044</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKinstry</surname><given-names>B</given-names></name><name><surname>Hammersley</surname><given-names>V</given-names></name><name><surname>Burton</surname><given-names>C</given-names></name><etal/></person-group><article-title>The quality, safety and content of telephone and face-to-face consultations: a comparative study.</article-title><source>Qual Saf Health Care</source><year>2010</year><volume>19</volume><issue>4</issue><fpage>298</fpage><lpage>303</lpage><pub-id pub-id-type="pmid">20430933</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helmes</surname><given-names>AW</given-names></name><name><surname>Culver</surname><given-names>JO</given-names></name><name><surname>Bowen</surname><given-names>DJ</given-names></name></person-group><article-title>Results of a randomized study of telephone versus in-person breast cancer risk counseling.</article-title><source>Patient Educ Couns</source><year>2006</year><volume>64</volume><issue>1-3</issue><fpage>96</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">16427245</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackenzie</surname><given-names>A</given-names></name><name><surname>Patrick-Miller</surname><given-names>L</given-names></name><name><surname>Bradbury</surname><given-names>AR</given-names></name></person-group><article-title>Controversies in communication of genetic risk for hereditary breast cancer.</article-title><source>Breast J</source><year>2009</year><volume>15</volume><issue>Suppl 1</issue><fpage>S25</fpage><lpage>S32</lpage><pub-id pub-id-type="pmid">19775327</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="other"><person-group person-group-type="author"><name><surname>Kinney</surname><given-names>AY</given-names></name><name><surname>Butler</surname><given-names>KM</given-names></name><name><surname>Boucher</surname><given-names>KM</given-names></name><etal/></person-group><source>Telephone vs. in-person genetic counseling for hereditary breast and ovarian cancer in urban and rural women: a cluster randomized trial. (Under editorial review)</source><year>2014</year></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armstrong</surname><given-names>K</given-names></name><name><surname>Micco</surname><given-names>E</given-names></name><name><surname>Carney</surname><given-names>A</given-names></name><name><surname>Stopfer</surname><given-names>J</given-names></name><name><surname>Putt</surname><given-names>M</given-names></name></person-group><article-title>Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.</article-title><source>JAMA</source><year>2005</year><volume>293</volume><issue>14</issue><fpage>1729</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">15827311</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forman</surname><given-names>AD</given-names></name><name><surname>Hall</surname><given-names>MJ</given-names></name></person-group><article-title>Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.</article-title><source>Breast J</source><year>2009</year><volume>15</volume><issue>Suppl 1</issue><fpage>S56</fpage><lpage>S62</lpage><pub-id pub-id-type="pmid">19775331</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peshkin</surname><given-names>BN</given-names></name><name><surname>Demarco</surname><given-names>TA</given-names></name><name><surname>Graves</surname><given-names>KD</given-names></name><etal/></person-group><article-title>Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial.</article-title><source>Genet Test</source><year>2008</year><volume>12</volume><issue>1</issue><fpage>37</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">18373403</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>DA</given-names></name><name><surname>Iversen</surname><given-names>ES</given-names><suffix>Jr.</suffix></name><name><surname>Gudbjartsson</surname><given-names>DF</given-names></name><etal/></person-group><article-title>BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.</article-title><source>J Clin Oncol</source><year>2002</year><volume>20</volume><issue>11</issue><fpage>2701</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">12039933</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erblich</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Valdimarsdottir</surname><given-names>HB</given-names></name><name><surname>Livingston</surname><given-names>BE</given-names></name><name><surname>Bovbjerg</surname><given-names>DH</given-names></name></person-group><article-title>Development and validation of a Breast Cancer Genetic Counseling Knowledge Questionnaire.</article-title><source>Patient Educ Couns</source><year>2005</year><volume>56</volume><issue>2</issue><fpage>182</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">15653247</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipkus</surname><given-names>IM</given-names></name><name><surname>Klein</surname><given-names>WM</given-names></name><name><surname>Rimer</surname><given-names>BK</given-names></name></person-group><article-title>Communicating breast cancer risks to women using different formats.</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2001</year><volume>10</volume><issue>8</issue><fpage>895</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11489757</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Connor</surname><given-names>AM</given-names></name></person-group><article-title>Validation of a decisional conflict scale.</article-title><source>Med Decis Making</source><year>1995</year><volume>15</volume><issue>1</issue><fpage>25</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">7898294</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horowitz</surname><given-names>M</given-names></name><name><surname>Wilner</surname><given-names>N</given-names></name><name><surname>Alvarez</surname><given-names>W</given-names></name></person-group><article-title>Impact of Event Scale: a measure of subjective stress.</article-title><source>Psychosom Med</source><year>1979</year><volume>41</volume><issue>3</issue><fpage>209</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">472086</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>S</given-names></name><name><surname>Kamarck</surname><given-names>T</given-names></name><name><surname>Mermelstein</surname><given-names>R</given-names></name></person-group><article-title>A global measure of perceived stress.</article-title><source>J Health Soc Behav</source><year>1983</year><volume>24</volume><issue>4</issue><fpage>385</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">6668417</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ware</surname><given-names>J</given-names><suffix>Jr.</suffix></name><name><surname>Kosinski</surname><given-names>M</given-names></name><name><surname>Keller</surname><given-names>SD</given-names></name></person-group><article-title>A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.</article-title><source>Med Care</source><year>1996</year><volume>34</volume><issue>3</issue><fpage>220</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">8628042</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busija</surname><given-names>L</given-names></name><name><surname>Pausenberger</surname><given-names>E</given-names></name><name><surname>Haines</surname><given-names>TP</given-names></name><name><surname>Haymes</surname><given-names>S</given-names></name><name><surname>Buchbinder</surname><given-names>R</given-names></name><name><surname>Osborne</surname><given-names>RH</given-names></name></person-group><article-title>Adult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQoL).</article-title><source>Arthritis Care Res (Hoboken)</source><year>2011</year><volume>63</volume><issue>Suppl 11</issue><fpage>S383</fpage><lpage>S412</lpage><pub-id pub-id-type="pmid">22588759</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dougall</surname><given-names>AL</given-names></name><name><surname>Smith</surname><given-names>AW</given-names></name><name><surname>Somers</surname><given-names>TJ</given-names></name><name><surname>Posluszny</surname><given-names>DM</given-names></name><name><surname>Rubinstein</surname><given-names>WS</given-names></name><name><surname>Baum</surname><given-names>A</given-names></name></person-group><article-title>Coping with genetic testing for breast cancer susceptibility.</article-title><source>Psychosom Med</source><year>2009</year><volume>71</volume><issue>1</issue><fpage>98</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">19124622</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoskins</surname><given-names>LM</given-names></name><name><surname>Werner-Lin</surname><given-names>A</given-names></name></person-group><article-title>A multi-case report of the pathways to and through genetic testing and cancer risk management for BRCA mutation-positive women aged 18-25.</article-title><source>J Genet Couns</source><year>2013</year><volume>22</volume><issue>1</issue><fpage>27</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">22864682</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoskins</surname><given-names>LM</given-names></name><name><surname>Greene</surname><given-names>MH</given-names></name></person-group><article-title>Anticipatory loss and early mastectomy for young female BRCA1/2 mutation carriers.</article-title><source>Qual Health Res</source><year>2012</year><volume>22</volume><issue>12</issue><fpage>1633</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">22927701</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graves</surname><given-names>KD</given-names></name><name><surname>Christopher</surname><given-names>J</given-names></name><name><surname>Harrison</surname><given-names>TM</given-names></name><name><surname>Peshkin</surname><given-names>BN</given-names></name><name><surname>Isaacs</surname><given-names>C</given-names></name><name><surname>Sheppard</surname><given-names>VB</given-names></name></person-group><article-title>Providers' perceptions and practices regarding BRCA1/2 genetic counseling and testing in African American women.</article-title><source>J Genet Couns</source><year>2011</year><volume>20</volume><issue>6</issue><fpage>674</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">21822773</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>DE</given-names></name><name><surname>Byfield</surname><given-names>SD</given-names></name><name><surname>Comstock</surname><given-names>CB</given-names></name><etal/></person-group><article-title>Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.</article-title><source>Genet Med</source><year>2011</year><volume>13</volume><issue>4</issue><fpage>349</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">21358336</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beal</surname><given-names>AC</given-names></name><name><surname>Doty</surname><given-names>MM</given-names></name><name><surname>Hernandez</surname><given-names>SE</given-names></name><name><surname>Shea</surname><given-names>KK</given-names></name><name><surname>Davis</surname><given-names>K</given-names></name></person-group><article-title>Changing the Divide: How Medical Homes Promote Equity in Health Care--Results from the Commonwealth Fund 2006 Health Care Quality Survey.</article-title><source>The Commonwealth Fund</source><month>6</month><year>2007</year></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cukier</surname><given-names>YR</given-names></name><name><surname>Thompson</surname><given-names>HS</given-names></name><name><surname>Sussner</surname><given-names>K</given-names></name><etal/></person-group><article-title>Factors associated with psychological distress among women of African descent at high risk for BRCA mutations.</article-title><source>J Genet Couns</source><year>2013</year><volume>22</volume><issue>1</issue><fpage>101</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22736212</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>LA</given-names></name><name><surname>Roter</surname><given-names>DL</given-names></name><name><surname>Johnson</surname><given-names>RL</given-names></name><name><surname>Ford</surname><given-names>DE</given-names></name><name><surname>Steinwachs</surname><given-names>DM</given-names></name><name><surname>Powe</surname><given-names>NR</given-names></name></person-group><article-title>Patient-centered communication, ratings of care, and concordance of patient and physician race.</article-title><source>Ann Intern Med</source><year>2003</year><volume>139</volume><issue>11</issue><fpage>907</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">14644893</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>HS</given-names></name><name><surname>Street</surname><given-names>RL</given-names><suffix>Jr.</suffix></name><name><surname>Sharf</surname><given-names>BF</given-names></name><name><surname>Souchek</surname><given-names>J</given-names></name></person-group><article-title>Racial differences in doctors' information-giving and patients' participation.</article-title><source>Cancer</source><year>2006</year><volume>107</volume><issue>6</issue><fpage>1313</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">16909424</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>RL</given-names></name><name><surname>Roter</surname><given-names>D</given-names></name><name><surname>Powe</surname><given-names>NR</given-names></name><name><surname>Cooper</surname><given-names>LA</given-names></name></person-group><article-title>Patient race/ethnicity and quality of patient-physician communication during medical visits.</article-title><source>Am J Public Health</source><year>2004</year><volume>94</volume><issue>12</issue><fpage>2084</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">15569958</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Smedley</surname><given-names>BD</given-names></name><name><surname>Stith</surname><given-names>AY</given-names></name><name><surname>Nelson</surname><given-names>AR</given-names></name></person-group><source>Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care</source><year>2003</year><publisher-name>National Academies Press</publisher-name><publisher-loc>Washington, DC</publisher-loc></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Street</surname><given-names>RL</given-names><suffix>Jr.</suffix></name><name><surname>O'Malley</surname><given-names>KJ</given-names></name><name><surname>Cooper</surname><given-names>LA</given-names></name><name><surname>Haidet</surname><given-names>P</given-names></name></person-group><article-title>Understanding concordance in patient-physician relationships: personal and ethnic dimensions of shared identity.</article-title><source>Ann Fam Med</source><year>2008</year><volume>6</volume><issue>3</issue><fpage>198</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">18474881</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thornton</surname><given-names>RL</given-names></name><name><surname>Powe</surname><given-names>NR</given-names></name><name><surname>Roter</surname><given-names>D</given-names></name><name><surname>Cooper</surname><given-names>LA</given-names></name></person-group><article-title>Patient-physician social concordance, medical visit communication and patients' perceptions of health care quality.</article-title><source>Patient Educ Couns</source><year>2011</year><volume>85</volume><issue>3</issue><fpage>e201</fpage><lpage>e208</lpage><pub-id pub-id-type="pmid">21840150</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agha</surname><given-names>Z</given-names></name><name><surname>Roter</surname><given-names>DL</given-names></name><name><surname>Schapira</surname><given-names>RM</given-names></name></person-group><article-title>An evaluation of patient-physician communication style during telemedicine consultations.</article-title><source>J Med Internet Res</source><year>2009</year><volume>11</volume><issue>3</issue><fpage>e36</fpage><pub-id pub-id-type="pmid">19793720</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>SA</given-names></name><name><surname>Marvin</surname><given-names>ML</given-names></name><name><surname>Riley</surname><given-names>BD</given-names></name><name><surname>Vig</surname><given-names>HS</given-names></name><name><surname>Rousseau</surname><given-names>JA</given-names></name><name><surname>Gustafson</surname><given-names>SL</given-names></name></person-group><article-title>Identification of genetic counseling service delivery models in practice: a report from the NSGC Service Delivery Model Task Force.</article-title><source>J Genet Couns</source><year>2013</year><volume>22</volume><issue>4</issue><fpage>411</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">23615968</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Consort diagram detailing study flow</p></caption><graphic xlink:href="nihms-624318-f0001"/></fig><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Race by group interaction in intention to treat sample</p></caption><graphic xlink:href="nihms-624318-f0002"/></fig><fig id="F3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Race by group interaction in per protocol sample</p></caption><graphic xlink:href="nihms-624318-f0003"/></fig><table-wrap id="T1" position="float" orientation="landscape"><label>Table 1</label><caption><p>Predictors of genetic testing uptake in intent-to-treat and per protocol analyses</p></caption><table frame="box" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="2" align="center" valign="top" rowspan="1">Genetic Testing (GT) Uptake Intent to Treat (N=669)</th><th colspan="2" align="center" valign="top" rowspan="1">Genetic Testing (GT) Uptake Per protocol (N=600)</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="center" valign="top" rowspan="1" colspan="1">Accepted GT (N=523)</th><th align="center" valign="top" rowspan="1" colspan="1">Declined GT (N=146)</th><th align="center" valign="top" rowspan="1" colspan="1">Accepted GT (N=523)</th><th align="center" valign="top" rowspan="1" colspan="1">Declined GT (N=77)</th></tr><tr><th colspan="5" align="left" valign="top" rowspan="1"><hr/></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1">Variable</th><th align="center" valign="top" rowspan="1" colspan="1">Mean (SD)</th><th align="center" valign="top" rowspan="1" colspan="1">Mean (SD)</th><th align="center" valign="top" rowspan="1" colspan="1">Mean (SD)</th><th align="center" valign="top" rowspan="1" colspan="1">Mean (SD)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold><italic>Continuous Predictors</italic></bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Age</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">47.7 (13.7)</td><td align="center" valign="top" rowspan="1" colspan="1">47.7 (12.3)</td><td align="center" valign="top" rowspan="1" colspan="1">47.7 (13.7)</td><td align="center" valign="top" rowspan="1" colspan="1">47.7 (12.0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>BRCAPRO Probability (%)</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">25.7 (23.3)</td><td align="center" valign="top" rowspan="1" colspan="1">22.4 (21.2)</td><td align="center" valign="top" rowspan="1" colspan="1">25.7 (23.3)</td><td align="center" valign="top" rowspan="1" colspan="1">18.1 (21.9)<sup><xref ref-type="table-fn" rid="TFN3">**</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Pre-test Knowledge</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">17.4 (4.5)</td><td align="center" valign="top" rowspan="1" colspan="1">16.2 (4.6)<sup><xref ref-type="table-fn" rid="TFN3">**</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">17.4 (4.5)</td><td align="center" valign="top" rowspan="1" colspan="1">16.0 (3.9)<sup><xref ref-type="table-fn" rid="TFN2">*</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Pre-test Numeracy</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">1.6 (0.9)</td><td align="center" valign="top" rowspan="1" colspan="1">1.5 (0.8)</td><td align="center" valign="top" rowspan="1" colspan="1">1.6 (0.9)</td><td align="center" valign="top" rowspan="1" colspan="1">1.6 (0.9)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Pre-test Impact of Events</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">21.6 (15.4)</td><td align="center" valign="top" rowspan="1" colspan="1">23.2 (15.3)</td><td align="center" valign="top" rowspan="1" colspan="1">21.6 (15.4)</td><td align="center" valign="top" rowspan="1" colspan="1">20.5 (14.0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Pre-test Perceived Stress</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">4.3 (2.4)</td><td align="center" valign="top" rowspan="1" colspan="1">4.9 (2.9)<sup><xref ref-type="table-fn" rid="TFN2">*</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">4.3 (2.4)</td><td align="center" valign="top" rowspan="1" colspan="1">4.6 (3.0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Pre-test Decisional Conflict</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">23.7 (9.6)</td><td align="center" valign="top" rowspan="1" colspan="1">22.2 (10.8)</td><td align="center" valign="top" rowspan="1" colspan="1">23.7 (9.6)</td><td align="center" valign="top" rowspan="1" colspan="1">22.2 (11.3)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>PCS 12</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">50.9 (8.9)</td><td align="center" valign="top" rowspan="1" colspan="1">49.9 (9.1)</td><td align="center" valign="top" rowspan="1" colspan="1">50.9 (8.9)</td><td align="center" valign="top" rowspan="1" colspan="1">49.2 (10.2)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>MCS 12</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">48.9 (10.5)</td><td align="center" valign="top" rowspan="1" colspan="1">48.1 (10.2)</td><td align="center" valign="top" rowspan="1" colspan="1">48.9 (10.5)</td><td align="center" valign="top" rowspan="1" colspan="1">49.8 (9.5)</td></tr></tbody></table><table frame="box" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Variable</th><th align="center" valign="top" rowspan="1" colspan="1">N (%) Completed)</th><th align="center" valign="top" rowspan="1" colspan="1">N (%) Declined</th><th align="center" valign="top" rowspan="1" colspan="1">N (%) Completed</th><th align="center" valign="top" rowspan="1" colspan="1">N (%) Declined</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold><italic>Categorical Predictors</italic></bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Randomization Arm</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">Usual Care</td><td align="center" valign="top" rowspan="1" colspan="1">272 (81.4)</td><td align="center" valign="top" rowspan="1" colspan="1">62 (18.6)<sup><xref ref-type="table-fn" rid="TFN2">*</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">272 (90.1)</td><td align="center" valign="top" rowspan="1" colspan="1">30 (9.9) <sup><xref ref-type="table-fn" rid="TFN2">*</xref></sup></td></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">Telephone</td><td align="center" valign="top" rowspan="1" colspan="1">251 (74.9)</td><td align="center" valign="top" rowspan="1" colspan="1">84 (25.1)</td><td align="center" valign="top" rowspan="1" colspan="1">251 (84.2)</td><td align="center" valign="top" rowspan="1" colspan="1">47 (15.8)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Education</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">&#x0003c; College Graduate</td><td align="center" valign="top" rowspan="1" colspan="1">96 (70.6)</td><td align="center" valign="top" rowspan="1" colspan="1">40 (29.4) <sup><xref ref-type="table-fn" rid="TFN2">*</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">96 (85.7)</td><td align="center" valign="top" rowspan="1" colspan="1">16 (14.3)</td></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">College Graduate <sup><xref ref-type="table-fn" rid="TFN1">+</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">427 (80.1)</td><td align="center" valign="top" rowspan="1" colspan="1">106 (19.9)</td><td align="center" valign="top" rowspan="1" colspan="1">427 (87.5)</td><td align="center" valign="top" rowspan="1" colspan="1">61 (12.5)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Marital Status</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">Not Married</td><td align="center" valign="top" rowspan="1" colspan="1">188 (74.6)</td><td align="center" valign="top" rowspan="1" colspan="1">64 (25.4) <sup><xref ref-type="table-fn" rid="TFN1">+</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">188 (83.2)</td><td align="center" valign="top" rowspan="1" colspan="1">38 (16.8)<sup><xref ref-type="table-fn" rid="TFN2">*</xref></sup></td></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">Married</td><td align="center" valign="top" rowspan="1" colspan="1">335 (80.3)</td><td align="center" valign="top" rowspan="1" colspan="1">82 (19.7)</td><td align="center" valign="top" rowspan="1" colspan="1">335 (89.6)</td><td align="center" valign="top" rowspan="1" colspan="1">39 (10.4)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Race<sup><xref ref-type="table-fn" rid="TFN4">#</xref></sup></bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">Non-white</td><td align="center" valign="top" rowspan="1" colspan="1">58 (63.7)</td><td align="center" valign="top" rowspan="1" colspan="1">33 (36.3)<sup><xref ref-type="table-fn" rid="TFN2">*</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">58 (80.6)</td><td align="center" valign="top" rowspan="1" colspan="1">14 (19.4)<sup><xref ref-type="table-fn" rid="TFN1">+</xref></sup></td></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">White</td><td align="center" valign="top" rowspan="1" colspan="1">458 (80.3)</td><td align="center" valign="top" rowspan="1" colspan="1">111 (19.7)</td><td align="center" valign="top" rowspan="1" colspan="1">458 (88.3)</td><td align="center" valign="top" rowspan="1" colspan="1">61 (11.7)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Employment</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">Not Employed</td><td align="center" valign="top" rowspan="1" colspan="1">226 (78.8)</td><td align="center" valign="top" rowspan="1" colspan="1">61(21.2)</td><td align="center" valign="top" rowspan="1" colspan="1">226 (87.3)</td><td align="center" valign="top" rowspan="1" colspan="1">33 (12.7)</td></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">Currently Employed</td><td align="center" valign="top" rowspan="1" colspan="1">297 (77.8)</td><td align="center" valign="top" rowspan="1" colspan="1">85 (22.2)</td><td align="center" valign="top" rowspan="1" colspan="1">297 (87.1)</td><td align="center" valign="top" rowspan="1" colspan="1">44 (12.9)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Jewish Ancestry</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">Non-Jewish</td><td align="center" valign="top" rowspan="1" colspan="1">364 (76.3)</td><td align="center" valign="top" rowspan="1" colspan="1">113 (23.7)<sup><xref ref-type="table-fn" rid="TFN1">+</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">364 (85.7)</td><td align="center" valign="top" rowspan="1" colspan="1">61 (14.3)<sup><xref ref-type="table-fn" rid="TFN1">+</xref></sup></td></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">Jewish</td><td align="center" valign="top" rowspan="1" colspan="1">159 (82.8)</td><td align="center" valign="top" rowspan="1" colspan="1">33 (17.2)</td><td align="center" valign="top" rowspan="1" colspan="1">159 (90.9)</td><td align="center" valign="top" rowspan="1" colspan="1">16 (9.1)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Perceived risk of BRCA mutation</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">&#x0003c; Very High</td><td align="center" valign="top" rowspan="1" colspan="1">380 (77.1)</td><td align="center" valign="top" rowspan="1" colspan="1">113 (22.9)</td><td align="center" valign="top" rowspan="1" colspan="1">380 (86.0)</td><td align="center" valign="top" rowspan="1" colspan="1">62 (14.0)</td></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">Very High</td><td align="center" valign="top" rowspan="1" colspan="1">143 (81.3)</td><td align="center" valign="top" rowspan="1" colspan="1">33 (18.7)</td><td align="center" valign="top" rowspan="1" colspan="1">143 (90.5)</td><td align="center" valign="top" rowspan="1" colspan="1">15 (9.5)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Perceived Breast Cancer Risk</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">&#x0003c; Very High</td><td align="center" valign="top" rowspan="1" colspan="1">434 (78.1)</td><td align="center" valign="top" rowspan="1" colspan="1">122 (21.9)</td><td align="center" valign="top" rowspan="1" colspan="1">434 (86.6)</td><td align="center" valign="top" rowspan="1" colspan="1">67 (13.4)</td></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">Very High</td><td align="center" valign="top" rowspan="1" colspan="1">89 (78.8)</td><td align="center" valign="top" rowspan="1" colspan="1">24 (11.2)</td><td align="center" valign="top" rowspan="1" colspan="1">89 (89.9)</td><td align="center" valign="top" rowspan="1" colspan="1">10 (10.1)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Perceived Ovarian Cancer Risk</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">&#x0003c; Very High</td><td align="center" valign="top" rowspan="1" colspan="1">496 (78.1)</td><td align="center" valign="top" rowspan="1" colspan="1">139 (21.9)</td><td align="center" valign="top" rowspan="1" colspan="1">496 (87.0)</td><td align="center" valign="top" rowspan="1" colspan="1">74 (13.0)</td></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">Very High</td><td align="center" valign="top" rowspan="1" colspan="1">27 (79.4)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (20.6)</td><td align="center" valign="top" rowspan="1" colspan="1">27 (90.0)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (10)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>RRM/RRO Intentions</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">Not considering RRM or RRO</td><td align="center" valign="top" rowspan="1" colspan="1">269 (76.2)</td><td align="center" valign="top" rowspan="1" colspan="1">84 (23.8)</td><td align="center" valign="top" rowspan="1" colspan="1">269 (84.3)</td><td align="center" valign="top" rowspan="1" colspan="1">50 (15.7)<sup><xref ref-type="table-fn" rid="TFN2">*</xref></sup></td></tr><tr><td align="right" valign="top" rowspan="1" colspan="1">Considering RRM or RRO</td><td align="center" valign="top" rowspan="1" colspan="1">254 (80.4)</td><td align="center" valign="top" rowspan="1" colspan="1">62 (19.6)</td><td align="center" valign="top" rowspan="1" colspan="1">254 (90.4)</td><td align="center" valign="top" rowspan="1" colspan="1">27 (9.6)</td></tr></tbody></table><table-wrap-foot><p><bold>Legend</bold></p><fn id="TFN1"><label>+</label><p id="P41">p&#x0003c;0.10</p></fn><fn id="TFN2"><label>*</label><p id="P42">p&#x0003c;0.05</p></fn><fn id="TFN3"><label>**</label><p id="P43">p&#x0003c;0.01</p></fn><fn id="TFN4"><label>#</label><p id="P44">For race analyses N = 660 for per protocol and 551 for intention-to-treat due to missing data</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float" orientation="landscape"><label>Table 2</label><caption><p>Logistic Regression Models Predicting Genetic Testing Uptake (Main Effect Models)</p></caption><table frame="box" rules="groups"><thead><tr><th colspan="3" align="left" valign="top" rowspan="1">GT Uptake &#x02013; Intent to Treat (ITT) (N=660)</th><th colspan="3" align="left" valign="top" rowspan="1">GT Uptake &#x02013; Per Protocol (PP) (N=591)</th></tr><tr><th colspan="6" align="left" valign="top" rowspan="1"><hr/></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1">Variables</th><th align="center" valign="top" rowspan="1" colspan="1">OR (95% CI)</th><th align="center" valign="top" rowspan="1" colspan="1">P value</th><th align="left" valign="top" rowspan="1" colspan="1">Variables</th><th align="center" valign="top" rowspan="1" colspan="1">OR (95% CI)</th><th align="center" valign="top" rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Randomization</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Randomization</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;TC (ref)</td><td align="center" valign="top" rowspan="1" colspan="1">--</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">TC (ref)</td><td align="center" valign="top" rowspan="1" colspan="1">--</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;UC</td><td align="center" valign="top" rowspan="1" colspan="1">1.48 (1.01,2.16)</td><td align="center" valign="top" rowspan="1" colspan="1">0.045</td><td align="left" valign="top" rowspan="1" colspan="1">UC</td><td align="center" valign="top" rowspan="1" colspan="1">1.65 (1.00,2.72)</td><td align="center" valign="top" rowspan="1" colspan="1">0.050</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Knowledge</td><td align="center" valign="top" rowspan="1" colspan="1">1.12 (1.02,1.23)<sup><xref ref-type="table-fn" rid="TFN5">+</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">0.018</td><td align="left" valign="top" rowspan="1" colspan="1">Marital Status</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Not Married (ref)</td><td align="center" valign="top" rowspan="1" colspan="1">--</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Married</td><td align="center" valign="top" rowspan="1" colspan="1">1.85 (1.12,3.08)</td><td align="center" valign="top" rowspan="1" colspan="1">0.017</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Race/ethnicity</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Minority (ref)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Non-Hispanic White</td><td align="center" valign="top" rowspan="1" colspan="1">1.96 (1.20,3.20)</td><td align="center" valign="top" rowspan="1" colspan="1">0.007</td><td align="left" valign="top" rowspan="1" colspan="1">BRCAPRO Probability</td><td align="center" valign="top" rowspan="1" colspan="1">1.22 (1.06,1.41)<sup><xref ref-type="table-fn" rid="TFN5">+</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">0.007</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PSS - Perceived stress</td><td align="center" valign="top" rowspan="1" colspan="1">0.89 (0.81,0.98)<sup><xref ref-type="table-fn" rid="TFN5">+</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">0.017</td><td align="left" valign="top" rowspan="1" colspan="1">Knowledge</td><td align="center" valign="top" rowspan="1" colspan="1">1.13 (1.00,1.27)<sup><xref ref-type="table-fn" rid="TFN5">+</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">0.050</td></tr></tbody></table><table-wrap-foot><p>* Variables removed via backwards elimination: PP: RRM/RRO Status (p=.12), Jewish Ethnicity (p=.19), Race/ethnicity (p=.62); ITT: Jewish Ethnicity (p=.35), Marital Status (p=.38), Education (p=.24)</p><fn id="TFN5"><label>+</label><p id="P45">OR and 95% CI reflect a 0.5 SD change.</p></fn></table-wrap-foot></table-wrap></floats-group></article>